Skip to main content
Guerbet logo

Guerbet — Investor Relations & Filings

Ticker · GBT ISIN · FR0000032526 LEI · 969500WV1U1WQ059L135 PA Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2024-11-13 Declaration of Voting R…
Country FR France
Listing PA GBT

About Guerbet

https://www.guerbet.com

Guerbet is a global specialist in medical imaging, offering a comprehensive range of solutions and services for diagnostic and interventional procedures. The company develops and manufactures contrast media, medical devices such as injectors, and related software for X-ray, Magnetic Resonance Imaging (MRI), and Interventional Imaging. With a history of innovation dating back to 1926, Guerbet focuses on providing healthcare professionals with tools to enhance diagnostic accuracy and improve patient care. Its portfolio is designed to support a wide array of clinical applications, from initial diagnosis to treatment monitoring.

Recent filings

Filing Released Lang Actions
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release dated November 13, 2024, titled "DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of voting rights and shares comprising the capital of the company). It explicitly states it is published in application of the French Commercial Code (L. 233-8 II) and AMF General Regulation (article 222-12-5), requiring monthly publication of the total number of voting rights and shares if they have changed. The content is a table detailing the total shares, treasury shares, and total/exercisable voting rights as of October 31, 2024. This specific requirement for monthly disclosure of voting rights and capital structure aligns directly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), which covers official results from shareholder votes or related statutory disclosures regarding voting rights.
2024-11-13 French
GUERBET : Financial agenda for 2025
Report Publication Announcement Classification · 98% confidence The document is titled "Financial agenda for 2025" and explicitly lists the dates for future publications, including '2024 ANNUAL REVENUE', '2024 ANNUAL RESULTS', '2025 1ST QUARTER REVENUE', and 'ANNUAL SHAREHOLDERS' MEETING'. This document is not the actual report or results, but rather an announcement detailing *when* those reports and events will be published. This fits the definition of a Report Publication Announcement (RPA), which signals the timing of future disclosures. The document length is short (2531 chars), supporting the idea that it is an announcement rather than a full report.
2024-10-31 English
GUERBET : Calendrier financier de l'exercice 2025
Report Publication Announcement Classification · 95% confidence The document is very short (2291 characters) and its primary content is the announcement of the 'Calendrier financier de l'exercice 2025' (Financial Calendar for fiscal year 2025) by the company Guerbet, along with contact information and a brief 'About Us' section. It is not a full financial report (like 10-K or IR), nor is it a transcript or a specific regulatory filing like a Director's Dealing or Dividend Notice. Since it is an announcement regarding the publication schedule of future financial information, and it doesn't fit neatly into the other specific categories, it is best classified as a general Regulatory Filing (RNS) or potentially a Report Publication Announcement (RPA) if it were announcing the release of a specific report. Given it's a schedule announcement, RNS is the most appropriate general regulatory announcement category, although RPA is also plausible if interpreted as announcing the schedule of report publications. I will lean towards RNS as the most general fit for an administrative announcement not covered elsewhere.
2024-10-31 French
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of voting rights and shares comprising the capital of the company). It explicitly references French regulations (Code de commerce and AMF general regulation) and provides a monthly update (as of September 30, 2024) detailing the total number of shares, treasury shares, and total voting rights. This content directly corresponds to the definition of a Declaration of Voting Results & Voting Rights Announcement, which is classified as AGM-R if it's the final result, or more generally, a specific regulatory disclosure. Given the options, the closest fit for a formal declaration of voting rights structure, even if not the *result* of a specific vote, is DVA, as it deals with the mechanics of voting rights. However, since this is a routine monthly disclosure of the capital structure and voting rights count, and not the result of a specific shareholder vote (which DVA usually implies), it is a specific regulatory filing concerning voting rights. Reviewing the definitions, DVA (Declaration of Voting Results & Voting Rights Announcements) is the most appropriate category for official disclosures regarding the total number of voting rights and shares, as it is a direct announcement related to voting mechanics.
2024-10-30 French
GUERBET : Chiffre d’affaires au 30 septembre 2024.
Earnings Release Classification · 100% confidence The document is a press release published on October 24, 2024, announcing the company's revenue ('Chiffre d'affaires') for the first nine months ending September 30, 2024. It provides key financial highlights, segment breakdowns, and confirms annual guidance. This format, focusing on period-specific financial results before the full annual report (10-K) or a comprehensive interim report (IR), aligns perfectly with an Earnings Release (ER). It is not a full Interim Report (IR) as it focuses on sales figures and guidance confirmation rather than a complete set of IFRS financial statements for the period, nor is it a Call Transcript (CT) or Investor Presentation (IP). 9M 2024
2024-10-24 French
GUERBET : Revenue at September 30, 2024.
Earnings Release Classification · 100% confidence The document explicitly states: "Guerbet (FR0000032526 GBT), a global specialist in contrast products and solutions for medical imaging, is publishing its revenue as at September 30, 2024. In the first nine months of the financial year, Group sales reached 620.5 million euros (€m)...". This content details the financial results for a period shorter than a full year (nine months) and presents comprehensive figures, tables, and management commentary on performance. This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). It is not an Earnings Release (ER) because it provides detailed breakdowns and commentary beyond just the initial highlights, and it is not the Annual Report (10-K) as it covers only nine months. 9M 2024
2024-10-24 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.